JW Jungwoo Vietnam Corporation 'Ubipharm JSC' Receives Appreciation Plaque for Overcoming COVID-19 Crisis Locally

JW Pharmaceutical's Vietnam subsidiary Ubipharm JSC announced on the 28th that it received a plaque of appreciation for its efforts in overcoming the COVID-19 crisis at the 'Long An Province Korcham Investment Council Launch Ceremony' held at the Long An Province Unification Hall on the 8th. Yang Gilchun, CEO of Ubipharm (fifth from the left), is receiving the plaque and posing for a commemorative photo. Photo by Yang Gilchun

[Asia Economy Reporter Lee Chun-hee] JW Pharmaceutical's Vietnam subsidiary, Ubipharm JSC, announced on the 28th that it received a plaque of appreciation for its efforts in overcoming the COVID-19 crisis at the 'Long An Province KOCHAM Investment Council Launch Ceremony' held recently at the Long An Province Unity Hall in Vietnam.

At the event hosted by the Long An Provincial People's Committee, Ubipharm was recognized for its contributions, including donating quarantine supplies to prevent the spread of COVID-19 in Long An, a key economic region in Vietnam, and supporting the launch of the KOCHAM Investment Council. The KOCHAM Investment Council is an official organization for mutual cooperation and information sharing among Korean companies in Long An. It was established to promote economic development based on cooperation between the Vietnamese government and the Long An local government.

Ubipharm donated 20,000 antipyretics and 40,000 health masks produced directly at its local factory and participated in raising charitable funds to overcome COVID-19 with the KOCHAM Investment Council. It also played an advisory role in the council's launch. Earlier, Ubipharm was selected as an excellent company for compliance with COVID-19 prevention guidelines and labor-management harmony at the Long An New Year Business Invitation event held in February.

Yang Gil-chun, CEO of Ubipharm, said, "We are pleased to be recognized for Ubipharm's contribution to the health of the Vietnamese people and the development of the healthcare industry," adding, "We will use this award as an opportunity to grow into a more respected pharmaceutical company in Vietnam."

Ubipharm is a local Vietnamese pharmaceutical company acquired by JW Pharmaceutical in 2019. JW Pharmaceutical's acquisition of Ubipharm is the first case of a domestic company acquiring full equity and directly operating a Vietnamese pharmaceutical company. JW Pharmaceutical plans to actively target the pharmaging market, including Vietnam and ASEAN countries, with medicines produced by Ubipharm. Ubipharm is a specialized company producing raw materials and finished pharmaceuticals with modern facilities, possessing the capacity to produce up to 1.937 billion units annually of powder injections, tablets, capsules, eye drops, and other pharmaceuticals, the largest scale in Vietnam.

This content was produced with the assistance of AI translation services.